Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
agreementwith, andincreased, Asia, attacked, backup, bowel, buyer, conclusion, considerationof, Crohn, customary, decisionfor, declaration, declared, dividend, donate, DPA, duty, emrusolmin, EPO, evolving, fine, forcontingent, fromintellectual, host, humanitarian, inflammatory, invoice, marked, Maryland, military, narrow, ng, OECD, ofATTENUKINETM, onF, orthern, OTE, pared, Pillar, primary, prosecution, refiled, rest, resultsin, reversedthe, Sanofi, shift, shortly, stipulated, stipulation, succeeded, terrorist, Thalomid, therapy, ulcerative, unaffected, utilizi, war, worth, written
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view